For instance, antibodies against CD9 and CD63, which are enriched on EVs, were administered to human breast cancer xenograft mouse models, and circulating administered EVs tagged by anti-CD9 and -CD63 were internalized by macrophages through phagocytosis, resulting in the inhibition of cancer progression [103]. Here, CD63 is linked to breast carcinoma.